The largest central quarantine site for COVID-19 cases with mild symptoms and asymptomatic infections in Shanghai was put into full operation on Tuesday night.
The production of a single-shot COVID-19 vaccine made by CanSino SPH Biologics Inc was launched in Shanghai on Thursday.
Expatriates in Shanghai can now make appointments to receive domestically developed COVID-19 booster shots.
A Shanghai hospital recently carried out the city's first online, transnational, multidisciplinary team consultations for four patients overseas.
The monoclonal neutralizing antibody cocktail is jointly developed by Brii Biosciences, Tsinghua University and the Third People's Hospital of Shenzhen.
Medical workers wearing cartoon head decorations work at a vaccination site in Shanghai, East China.
On November 26, the World Health Organization has officially designated a new strain of novel coronavirus as the Omicron variant.
Shanghai will begin registration for COVID-19 vaccination for children aged 3 to 5 on Thursday at 8 pm.